Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Cisatracurium besylate 2 mg/mL, 5 mg/mL Injection, solution Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom Nimbex Beclomethasone dipropionate 100g/dose Inhaler, aerosol, metered 3M Healthcare (UK) Limited, Loughborough, Leicestershire, England Qvar 100 Autohaler Beclomethasone dipropionate 100g/dose Inhaler, aerosol, metered 3M Healthcare (UK) Limited, Loughborough, Leicestershire, England Qvar 100 Inhaler Beclomethasone dipropionate 50g/dose Inhaler, aerosol, metered 3M Healthcare (UK) Limited, Loughborough, Leicestershire, England Qvar 50 Autohaler Beclomethasone dipropionate 50g/dose Inhaler, aerosol, metered 3M Healthcare (UK) Limited, Loughborough, Leicestershire, England Qvar 50 Inhaler Salbutamol sulphate equivalent to 1 mg/mL, 2 mg/mL salbutamol Inhalation, solution Boehringer Ingelheim Limited, Bracknell, Berkshire, England Salbutamol Respules Sodium cromoglycate 5 mg/dose Inhaler, aerosol, metered Rhone-Poulenc Rorer, Holmes Chapel, Cheshire, England Vicrom CFC-Free Dated this 11th day of January 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
14 Jan 1999

Notice Number

1999-go345

Page Number

57